Created at	Source	Raw Value	Validated value
Feb. 22, 2022, 6 p.m.	usa	Change from baseline in geometric mean titer of IgGs specific to S protein;Change from baseline in Geometric mean titer of neutralizing antibodies to SARS-Cov-2 virus;Change from baseline in Number of participants with detected neutralizing antibodies to SARS-Cov-2 virus;Change from baseline in Number of participants with detected specific IgAs;Change from baseline in number of participants with detected specific IgGs;Proportion of participants with any adverse events;Proportion of participants with severe adverse events	Change from baseline in geometric mean titer of IgGs specific to S protein;Change from baseline in Geometric mean titer of neutralizing antibodies to SARS-Cov-2 virus;Change from baseline in Number of participants with detected neutralizing antibodies to SARS-Cov-2 virus;Change from baseline in Number of participants with detected specific IgAs;Change from baseline in number of participants with detected specific IgGs;Proportion of participants with any adverse events;Proportion of participants with severe adverse events